Propanc Biopharma (PPCB) Other Accumulated Expenses (2014 - 2026)
Propanc Biopharma's Other Accumulated Expenses came in at $128,318 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 32.7% from $190,795 a year earlier.
Powered by 
Analysis
Propanc Biopharma (PPCB) Other Accumulated Expenses (2014 - 2026) Analysis & Trends
Going back to fiscal Q4 2014, Propanc Biopharma's Other Accumulated Expenses data covers 23 quarters.
- Other Accumulated Expenses carries a four-year compound annual growth rate of 22.1% (FY2022 to FY2026).
- Going back by fiscal year, Other Accumulated Expenses was $190,795 in FY2025 (+101.7%), $94,612 in FY2024 (+111.6%), $44,709 in FY2023 (-22.7%) and $57,822 in FY2022.
- The fiscal Q4 2026 figure represents the lowest quarterly Other Accumulated Expenses since fiscal Q1 2025.
- Year-over-year, Other Accumulated Expenses increased in six of the last seven quarters, with growth averaging 63.5%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in fiscal Q1 2025 (growth of 111.7%), and the weakest in fiscal Q4 2026 (a decline of 32.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Propanc Biopharma | 561,854.50 | 561,854.50 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 128,318.00 |
| Dec 31, 2025 | 168,152.00 |
| Sep 30, 2025 | 150,443.00 |
| Jun 30, 2025 | 190,795.00 |
| Mar 31, 2025 | 167,592.00 |
| Dec 31, 2024 | 135,351.00 |
| Sep 30, 2024 | 111,652.00 |
| Jun 30, 2024 | 94,612.00 |
| Mar 31, 2024 | 83,310.00 |
| Dec 31, 2023 | 66,319.00 |
| Sep 30, 2023 | 52,743.00 |
| Jun 30, 2023 | 44,709.00 |
| Mar 31, 2023 | 56,661.00 |
| Dec 31, 2022 | 59,733.00 |
| Jun 30, 2022 | 57,822.00 |
| Mar 31, 2020 | 1.01 Mn |
| Dec 31, 2019 | 826,853.00 |
| Jun 30, 2019 | 917,337.00 |
| Mar 31, 2017 | 15,617.00 |
| Dec 31, 2016 | 76,435.00 |
API Access
Propanc Biopharma Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();